News & Media


Larner College of Medicine in the Media

The following news and stories about LCOM appeared in local and/or national media.


Cunniff Lab Data Shared at World Conference on Lung Cancer, New Sarawak Tribune Reports

September 18, 2023 by Lucy Gardner Carson

(SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.

Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine. in Larner’s Cunniff Laboratory

(SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.

The data represented a partnership between RS Oncology and other lead research institutions, including the University of Leicester and the Cunniff Laboratory at the University of Vermont Cancer Center.

Using biphasic mesotheliomas as a model containing both epithelioid and sarcomatoid features, investigators at the University of Leicester conducted a geospatial analysis of patient tissues to explore the molecular signatures associated with the histological regions. The group found that the more aggressive sarcomatoid regions had distinct molecular signatures driving pro-tumor pathways, drug resistance, and increased metastatic potential, using sophisticated spatial analysis tools coupled with machine learning approaches. In collaboration with Cunniff’s lab, the team then evaluated molecular signatures of human biphasic mesothelioma tumor cells following treatment with the irreversible PRX3 inhibitor RSO-021.

This is currently being evaluated in a phase I/II clinical trial in patients with malignant pleural effusion caused by advanced/metastatic solid tumors.

Read full story at New Sarawak Tribune (Malaysia)

Larner College of Medicine News

Recent news and stories from the college.

Cunniff Lab Data Shared at World Conference on Lung Cancer, New Sarawak Tribune Reports

September 18, 2023 by Lucy Gardner Carson

(SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.

Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine. in Larner’s Cunniff Laboratory

(SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.

The data represented a partnership between RS Oncology and other lead research institutions, including the University of Leicester and the Cunniff Laboratory at the University of Vermont Cancer Center.

Using biphasic mesotheliomas as a model containing both epithelioid and sarcomatoid features, investigators at the University of Leicester conducted a geospatial analysis of patient tissues to explore the molecular signatures associated with the histological regions. The group found that the more aggressive sarcomatoid regions had distinct molecular signatures driving pro-tumor pathways, drug resistance, and increased metastatic potential, using sophisticated spatial analysis tools coupled with machine learning approaches. In collaboration with Cunniff’s lab, the team then evaluated molecular signatures of human biphasic mesothelioma tumor cells following treatment with the irreversible PRX3 inhibitor RSO-021.

This is currently being evaluated in a phase I/II clinical trial in patients with malignant pleural effusion caused by advanced/metastatic solid tumors.

Read full story at New Sarawak Tribune (Malaysia)

Media Relations

To schedule an interview with a faculty member, student, or staff member at the UVM Larner College of Medicine, contact: 

Angela Ferrante, Public Relations Manager
Office
: (802) 656-3111
Mobile: (516) 458-0721